VAERS Explorer
Back to explore

Report #2827344

Received Feb 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
54 yrs
State
CO
Recovered
Not recovered
Vaccinated
Jan 17, 2025
Onset
Jan 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1X72D2IM / RA

Symptoms (4)

Facial paralysisHeadachePain in extremitySwelling face

Symptom narrative

new symptom of drooping on left lip has started; patient experienced right arm pain (vaccination was given there); headache; swollen from left eye down to lips; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number X72D2, expiry date 30-JAN-2027) for prophylaxis. On 17-JAN-2025, the patient received the 1st dose of Shingrix (intramuscular, right deltoid). On 17-JAN-2025, 12 hrs after receiving Shingrix, the patient experienced pain in arm (Verbatim: patient experienced right arm pain (vaccination was given there)), headache (Verbatim: headache) and facial swelling (Verbatim: swollen from left eye down to lips). On 20-JAN-2025, the patient experienced facial muscle weakness (Verbatim: new symptom of drooping on left lip has started). On 22-JAN-2025, the outcome of the pain in arm and headache were resolved and the outcome of the facial muscle weakness was resolved (duration 2 days). The outcome of the facial swelling was resolved. It was unknown if the reporter considered the pain in arm, headache, facial swelling and facial muscle weakness to be related to Shingrix. It was unknown if the company considered the pain in arm, headache, facial swelling and facial muscle weakness to be related to Shingrix. Additional Information: GSK Receipt Date: 22-JAN-2025 Reporter was the patient who received her first Shingrix vaccine on 17th January 2025. Within the first 12 hours patient experienced right arm pain (vaccination was given there), headache, swollen from left eye down to lips. On the day of reporting 22nd January 2025, right arm pain, swelling from left eye down to lip and headache has subsided, however, on 20th January 2025, new symptom of drooping on left lip has started. Caller did reach out to the Clinic where she received the vaccine and was told to speak with her healthcare professional.